.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Analyze global market entry opportunities
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Covington
Fish and Richardson
AstraZeneca
Accenture
Cerilliant
Chinese Patent Office
Merck
Deloitte
Federal Trade Commission

Generated: June 22, 2017

DrugPatentWatch Database Preview

PREMPHASE (PREMARIN;CYCRIN 14/14) Drug Profile

« Back to Dashboard

Which patents cover Premphase (premarin;cycrin 14/14), and when can generic versions of Premphase (premarin;cycrin 14/14) launch?

Premphase (premarin;cycrin 14/14) is a drug marketed by Wyeth Pharms Inc and is included in one NDA.

The generic ingredient in PREMPHASE (PREMARIN;CYCRIN 14/14) is estrogens, conjugated; medroxyprogesterone acetate. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the estrogens, conjugated; medroxyprogesterone acetate profile page.

Summary for Tradename: PREMPHASE (PREMARIN;CYCRIN 14/14)

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list40
Clinical Trials: see list34
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PREMPHASE (PREMARIN;CYCRIN 14/14) at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms Inc
PREMPHASE (PREMARIN;CYCRIN 14/14)
estrogens, conjugated; medroxyprogesterone acetate
TABLET;ORAL-28020303-002Dec 30, 1994DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: PREMPHASE (PREMARIN;CYCRIN 14/14)

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms Inc
PREMPHASE (PREMARIN;CYCRIN 14/14)
estrogens, conjugated; medroxyprogesterone acetate
TABLET;ORAL-28020303-002Dec 30, 19945,210,081► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Accenture
Novartis
Farmers Insurance
Federal Trade Commission
Cerilliant
US Army
Teva
Harvard Business School
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot